Perception of Risk and Communication Among Conventional and Complementary Health Care Providers Involving Cancer Patients' Use of Complementary Therapies: a Literature Review

Overview

Journal BMC Complement Altern Med

Publisher Biomed Central

Specialty Rehabilitation Medicine

Date 2016 Sep 10

PMID 27609097

Citations 39

Authors

Trine Stub

Sara A Quandt

Thomas A Arcury

Joanne C Sandberg

Agnete E Kristoffersen

Frauke Musial

Anita Salamonsen

Affiliations

Soon will be listed here.

Abstract

Background: Communication between different health care providers (conventional and complementary) and cancer patients about their use of complementary therapies affects the health and safety of the patients. The aim of this study was to examine the qualitative research literature on the perception of and communication about the risk of complementary therapies between different health care providers and cancer patients.

Methods: Systematic searches in six medical databases covering literature from 2000 to 2015 were performed. The studies were accessed according to the level of evidence and summarized into different risk situations. Qualitative content analysis was used to analyze the text data, and the codes were defined before and during the data analysis.

Results: Twenty-nine papers were included in the primary analysis and five main themes were identified and discussed. The main risk situations identified were 1. Differences in treatment concepts and philosophical values among complementary and conventional health care providers. 2. Adverse effects from complementary products and herbs due to their contamination/toxicity and interactions with conventional cancer treatment. 3. Health care physicians and oncologists find it difficult to recommend many complementary modalities due to the lack of scientific evidence for their effect. 4. Lack of knowledge and information about complementary and conventional cancer treatments among different health care providers.

Conclusion: The risk of consuming herbs and products containing high level of toxins is a considerable threat to patient safety (direct risk). At the same time, the lack of scientific evidence of effect for many complementary therapies and differences in treatment philosophy among complementary and conventional health care providers potentially hinder effective communication about these threats with mutual patients (indirect risk). As such, indirect risk may pose an additional risk to patients who want to combine complementary therapies with conventional treatment in cancer care. Health care providers who care for cancer patients should be aware of these risks.

Citing Articles

A Survey on the Prescribing Orientation Towards Complementary Therapies Among Oncologists in Italy: Symptoms and Unmet Patient Needs.

Valerio M, Scandurra G, Greco M, Gebbia V, Piazza D, Sambataro D In Vivo. 2025; 39(2):1000-1008.

PMID: 40010972 PMC: 11884454. DOI: 10.21873/invivo.13905.

Awareness of Contraindications Among Cancer Patients in Riyadh, Saudi Arabia: A Cross-Sectional Study.

Almuqbil M, Alobaid R, Alhamad A, Eddin N, Yahya N, Alsanie W Cancer Control. 2025; 32():10732748251313498.

PMID: 39825865 PMC: 11742164. DOI: 10.1177/10732748251313498.

Education about complementary and alternative medicine in cancer self-help groups by trained peers.

Weis J, Jablotschkin M, Horneber M, Steinmann D, Witt C, Helmer S BMC Complement Med Ther. 2024; 24(1):373.

PMID: 39427169 PMC: 11491026. DOI: 10.1186/s12906-024-04680-2.

Use and perception of risk: traditional medicines of Pakistani immigrants in Norway.

Khalid S, Kristoffersen A, Alpers L, Borge C, Qureshi S, Stub T BMC Complement Med Ther. 2024; 24(1):331.

PMID: 39244539 PMC: 11380776. DOI: 10.1186/s12906-024-04620-0.

Oncology researchers' and clinicians' perceptions of complementary, alternative, and integrative medicine: an international, cross-sectional survey.

Ng J, Kochhar J, Cramer H Support Care Cancer. 2024; 32(9):615.

PMID: 39196463 PMC: 11358342. DOI: 10.1007/s00520-024-08785-9.

References

Baynham-Fletcher L, Babiak-Vazquez A, Cuello D, Frenkel M . Credentialing complementary practitioners in a large academic cancer center. J Soc Integr Oncol. 2009; 6(4):169-75. View

Mazor K, Gaglio B, Nekhlyudov L, Alexander G, Stark A, Hornbrook M . Assessing patient-centered communication in cancer care: stakeholder perspectives. J Oncol Pract. 2013; 9(5):e186-93. PMC: 3770509. DOI: 10.1200/JOP.2012.000772. View

Broom A, Doron A . Traditional medicines, collective negotiation, and representations of risk in Indian cancer care. Qual Health Res. 2012; 23(1):54-65. DOI: 10.1177/1049732312462242. View

Kaptchuk T, EISENBERG D . Varieties of healing. 2: a taxonomy of unconventional healing practices. Ann Intern Med. 2001; 135(3):196-204. DOI: 10.7326/0003-4819-135-3-200108070-00012. View

Peter M, Ann C, Sam P, Jacqui S, Dai R, Andrew L . Complementary therapists' motivation to work in cancer/supportive and palliative care: a multi-centre case study. Complement Ther Clin Pract. 2009; 15(3):161-5. DOI: 10.1016/j.ctcp.2009.03.004. View

Verhoef M, Boon H, Page S . Talking to cancer patients about complementary therapies: is it the physician's responsibility?. Curr Oncol. 2008; 15 Suppl 2:s88-93. PMC: 2528563. DOI: 10.3747/co.v15i0.279. View

Richardson P . Assessment and implementation of spirituality and religiosity in cancer care: effects on patient outcomes. Clin J Oncol Nurs. 2012; 16(4):E150-5. DOI: 10.1188/12.CJON.E150-E155. View

Barrett B, Marchand L, Scheder J, Appelbaum D, Chapman M, Jacobs C . Bridging the gap between conventional and alternative medicine. J Fam Pract. 2000; 49(3):234-9. View

Frenkel M, Ben-Arye E, Cohen L . Communication in cancer care: discussing complementary and alternative medicine. Integr Cancer Ther. 2010; 9(2):177-85. DOI: 10.1177/1534735410363706. View

10.

Schofield P, Diggens J, Charleson C, Marigliani R, Jefford M . Effectively discussing complementary and alternative medicine in a conventional oncology setting: communication recommendations for clinicians. Patient Educ Couns. 2009; 79(2):143-51. DOI: 10.1016/j.pec.2009.07.038. View

11.

OMalley A, D Reschovsky J . Referral and consultation communication between primary care and specialist physicians: finding common ground. Arch Intern Med. 2011; 171(1):56-65. DOI: 10.1001/archinternmed.2010.480. View

12.

Roberts D, McNulty A, Caress A . Current issues in the delivery of complementary therapies in cancer care--policy, perceptions and expectations: an overview. Eur J Oncol Nurs. 2005; 9(2):115-23. DOI: 10.1016/j.ejon.2005.03.008. View

13.

Verhoef M, Weeks L, Brazier A, Leis A . Evaluating supportive cancer care: are we missing an opportunity?. Support Care Cancer. 2007; 15(8):905-7. DOI: 10.1007/s00520-007-0289-9. View

14.

Ben-Arye E, Schiff E, Zollman C, Heusser P, Mountford P, Frenkel M . Integrating complementary medicine in supportive cancer care models across four continents. Med Oncol. 2013; 30(2):511. DOI: 10.1007/s12032-013-0511-1. View

15.

Salamonsen A . Doctor-patient communication and cancer patients' choice of alternative therapies as supplement or alternative to conventional care. Scand J Caring Sci. 2012; 27(1):70-6. DOI: 10.1111/j.1471-6712.2012.01002.x. View

16.

Schiff E, Frenkel M, Shilo M, Levy M, Schachter L, Freifeld Y . Bridging the physician and CAM practitioner communication gap: suggested framework for communication between physicians and CAM practitioners based on a cross professional survey from Israel. Patient Educ Couns. 2010; 85(2):188-93. DOI: 10.1016/j.pec.2010.08.029. View

17.

Frenkel M, Ben-Arye E, Baldwin C, Sierpina V . Approach to communicating with patients about the use of nutritional supplements in cancer care. South Med J. 2005; 98(3):289-94. DOI: 10.1097/01.SMJ.0000154776.71057.E8. View

18.

Molassiotis A, Fernandez-Ortega P, Pud D, Ozden G, Scott J, Panteli V . Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005; 16(4):655-63. DOI: 10.1093/annonc/mdi110. View

19.

Hsieh H, Shannon S . Three approaches to qualitative content analysis. Qual Health Res. 2005; 15(9):1277-88. DOI: 10.1177/1049732305276687. View

20.

Wiesener S, Falkenberg T, Hegyi G, Hok J, Roberti di Sarsina P, Fonnebo V . Legal status and regulation of complementary and alternative medicine in Europe. Forsch Komplementmed. 2013; 19 Suppl 2:29-36. DOI: 10.1159/000343125. View